SAN FRANCISCO, Sept. 17, 2019 — Hagens Berman reminds BGNE investors that it has launched an investigation into BeiGene, Ltd. (NASDAQ: BGNE) regarding possible violations of Federal securities laws, and is urging investors to find out their rights.
On Sept. 5, 2019, J Capital Research (“JCAP”) published a scathing report about BeiGene, suggesting the company includes fake sales in its reported financial statements. On this news, the price of BGNE shares fell sharply.
If you invested in SONM before Sept. 5, 2019 and suffered significant losses, contact Hagens Berman immediately to discuss your options
“We are focused on investors’ losses and the propriety of the company’s financial reporting,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding BeiGene should consider their options to help in the investigation or take advantage of the SEC whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman Hagens Berman is a national law with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000